文献速递眼底病与葡萄膜炎

眼底控制视野检查(微视野)作为临床试验结局指标的应用

Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials.
PubMed 文献 · Prog Retin Eye Res · 2020-10-03

本文综述眼底控制视野检查(FCP,又称微视野)的技术原理与临床应用,指出其可空间分辨地映射视觉敏感度和测量注视稳定性,比最佳矫正视力更能反映疾病严重程度与进展。眼底追踪和精确逐点随访可改善会话内和会话间重测变异性,疾病特异性测试模式与暗适应色觉及明适应测试有助于优化临床试验结局指标。

要点

  • FCP可空间分辨映射视觉敏感度并测量注视稳定性,提供BCVA未反映的疾病信息。
  • 眼底追踪与逐点随访改善重测变异性,适用于注视不稳定患者。
  • 疾病特异性测试模式与暗适应色觉、明适应测试可减少检查负担并实现光感受器特异性评估。

核心结论

  • FCP可空间分辨地映射视觉敏感度和测量注视稳定性,作为临床试验结局指标具有潜力。

研究设计与样本

  • 本文为叙述性综述,描述FCP的理论与技术背景、既往临床与研究应用、支持其作为临床试验结局指标的数据以及正在和未来的发展。

主要发现

  • FCP提供的视觉功能空间特征可反映疾病严重程度与进展,而最佳矫正视力在多种疾病中不能反映这些信息。
  • 眼底追踪和精确逐点随访检查可改善会话内和会话间重测变异性,即使注视不稳定患者亦然。
  • 疾病特异性测试模式和方案可减少广泛耗时的FCP检查负担,实现更有意义和聚焦的应用。
  • 近期发展通过暗适应色觉和明适应测试实现光感受器特异性测试。

关键数值与推荐

  • FCP可空间分辨地映射视觉敏感度并测量注视稳定性,适用于临床实践和研究。
  • 眼底追踪和逐点随访可改善会话内和会话间重测变异性。
  • 疾病特异性测试模式和方案可减少检查负担。
  • 暗适应色觉和明适应测试可实现光感受器特异性测试。

临床怎么用

  • 在临床试验和自然史研究中,可依据FCP设备与测试设置设计并优化FCP方案作为结局指标。
  • 对早期不累及中心视网膜的视网膜疾病,FCP可提供BCVA未反映的视觉功能信息。
  • 对注视不稳定患者,可利用眼底追踪和逐点随访改善重测变异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fundus-controlled perimetry (FCP, also called 'microperimetry') allows for spatially-resolved mapping of visual sensitivity and measurement of fixation stability, both in clinical practice as well as research. The accurate spatial characterization of visual function enabled by FCP can provide insightful information about disease severity and progression not reflected by best-corrected visual acuity in a large range of disorders. This is especially important for monitoring of retinal diseases that initially spare the central retina in earlier disease stages. Improved intra- and inter-session retest-variability through fundus-tracking and precise point-wise follow-up examinations even in patients with unstable fixation represent key advantages of these technique. The design of disease-specific test patterns and protocols reduces the burden of extensive and time-consuming FCP testing, permitting a more meaningful and focused application. Recent developments also allow for photoreceptor-specific testing through implementation of dark-adapted chromatic and photopic testing. A detailed understanding of the variety of available devices and test settings is a key prerequisite for the design and optimization of FCP protocols in future natural history studies and clinical trials. Accordingly, this review describes the theoretical and technical background of FCP, its prior application in clinical and research settings, data that qualify the application of FCP as an outcome measure in clinical trials as well as ongoing and future developments.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Pfau M, Jolly JK, Wu Z, et al. Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials. Prog Retin Eye Res. 2020. PMID: 33022378. doi:10.1016/j.preteyeres.2020.100907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。